Home Cart 0 Sign in  

[ CAS No. 896722-50-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 896722-50-2
Chemical Structure| 896722-50-2
Structure of 896722-50-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 896722-50-2 ]

Related Doc. of [ 896722-50-2 ]

Alternatived Products of [ 896722-50-2 ]

Product Details of [ 896722-50-2 ]

CAS No. :896722-50-2 MDL No. :MFCD11616448
Formula : C13H9ClN2O2S Boiling Point : -
Linear Structure Formula :- InChI Key :MLCIWUYAGVFRMD-UHFFFAOYSA-N
M.W : 292.74 Pubchem ID :49759033
Synonyms :

Calculated chemistry of [ 896722-50-2 ]

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 15
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 73.81
TPSA : 60.34 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.64 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.26
Log Po/w (XLOGP3) : 3.45
Log Po/w (WLOGP) : 4.01
Log Po/w (MLOGP) : 2.95
Log Po/w (SILICOS-IT) : 1.91
Consensus Log Po/w : 2.91

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.28
Solubility : 0.0153 mg/ml ; 0.0000524 mol/l
Class : Moderately soluble
Log S (Ali) : -4.4
Solubility : 0.0117 mg/ml ; 0.00004 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -5.14
Solubility : 0.00214 mg/ml ; 0.00000731 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.62

Safety of [ 896722-50-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 896722-50-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 896722-50-2 ]
  • Downstream synthetic route of [ 896722-50-2 ]

[ 896722-50-2 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 896722-50-2 ]
  • [ 824-51-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 8, p. 3076 - 3080
  • 2
  • [ 98-09-9 ]
  • [ 896722-50-2 ]
YieldReaction ConditionsOperation in experiment
80.7%
Stage #1: With sodium hydride In tetrahydrofuran at 0 - 20℃; for 1 h;
Stage #2: at 20℃; for 1 h;
(R)-6-Chloro-2-pyrrolidin-2-ylmethyl-1H-pyrrolo[2,3-b]pyridine. (Compound 45A) and (S)-6-Chloro-2-pyrrolidin-2-ylmethyl-1H-pyrrolo[2,3-b]pyridine. (Compound 45B); 6-Chloro-7-azaindole (9.3 g, 61.1 mmol), prepared as described (Synthesis, 1992), was dissolved in 100 ml anhydrous THF under N2. At 0° C., a 60percent dispersion of NaH 3.5 g (65.9 mmol) in mineral oil was added. After stirring for 1 hour at room temperature, the mixture was cooled (0° C.) and 8.7 ml (67.2 mmol) benzenesulfonyl chloride dissolved in 20 ml anhydrous THF was added. The reaction mixture was stirred at room temperature for 1 hour. Ethyl acetate was added to the mixture and the organic layer was washed three times with a saturated NaHCO3 solution, dried (Na2SO4), filtered and concentrated. The resulting residue was purified by flash chromatography (diethyl ether/PE gradient (1:4 to pure diethyl ether) to give 1-benzenesulfonyl-6-chloro-1H-pyrrolo[2,3-b]pyridine (amorphous, 14.4 g, 80.7percent) (TLC diethyl ether/PE (1/1) Rf 0.37). LCMS; Rt: 1.98 min, ([M+H]+=293).
Reference: [1] Patent: US2008/9514, 2008, A1, . Location in patent: Page/Page column 21
  • 3
  • [ 98-11-3 ]
  • [ 55052-27-2 ]
  • [ 896722-50-2 ]
YieldReaction ConditionsOperation in experiment
32%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; paraffin oil at 0 - 20℃; for 0.5 h;
Stage #2: at 20℃; for 3 h;
To a solution of 6-chloro-1 H-pyrrolo[2,3-b]pyridine (1.37 g, 8.97 mmol) in DMF (1 00 ml),sodium hydride (60percent in paraffin, 1 g, 41 mmol) was added. The solution was stirred for30 min being allowed to warm up from 0 oc to rt. Subsequently, benzenesulfonic acidchloride (1.5 ml, 11.8 mmol) was added dropwise. The suspension was stirred 3 h atroom temperature and hydrolyzed with ice water. The resulting solid was filtered off under25 reduced pressure, washed thoroughly with water (75 ml) and finally with petroleum ether(15 ml). The resulting material was dried at 60 oc and purified by column chromatography (eluent: pure dichloromethane) yielding 856 mg of 1-(benzenesulfonyl)-6-chloropyrrolo[2,3-b]pyridine Xll-20a as a brownish solid.Yield: 32percent
Reference: [1] Patent: WO2018/122232, 2018, A1, . Location in patent: Page/Page column 260; 261
  • 4
  • [ 98-09-9 ]
  • [ 55052-27-2 ]
  • [ 896722-50-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 8, p. 3076 - 3080
[2] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 1, p. 188 - 193
  • 5
  • [ 271-63-6 ]
  • [ 896722-50-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 8, p. 3076 - 3080
  • 6
  • [ 143468-07-9 ]
  • [ 896722-50-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 8, p. 3076 - 3080
  • 7
  • [ 55052-24-9 ]
  • [ 896722-50-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 8, p. 3076 - 3080
  • 8
  • [ 896722-50-2 ]
  • [ 5158-46-3 ]
  • [ 896722-51-3 ]
YieldReaction ConditionsOperation in experiment
88%
Stage #1: With tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran for 40 h; Heating / reflux
Stage #2: With water In tetrahydrofuran at 0℃;
A solution of methylzinc chloride in THF (2 M) (9 mL, 12 mmol) was added to 6-chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine (0.600 g, 2.05 mmol) and Pd(PPh3)4 (0.095 g, 0.08 mmol) in THF (30 mL). The mixture was refluxed for 40 h, cooled to 0° C., quenched with water and extracted with Et2O. The organic layer was concentrated and the residue was purified over a silica gel column eluting with EtOAc/hexane (1:5) to give N-protected 6-methyl-7-azaindole (0.495 g, 88percent).
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 8, p. 3076 - 3080
[2] Patent: US2006/148801, 2006, A1, . Location in patent: Page/Page column 11
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 896722-50-2 ]

Aryls

Chemical Structure| 348640-02-8

[ 348640-02-8 ]

1-Tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.93

Chemical Structure| 896722-51-3

[ 896722-51-3 ]

6-Methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.89

Chemical Structure| 934524-10-4

[ 934524-10-4 ]

2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.88

Chemical Structure| 348640-07-3

[ 348640-07-3 ]

4-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.86

Chemical Structure| 880769-95-9

[ 880769-95-9 ]

3-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.85

Chlorides

Chemical Structure| 934524-10-4

[ 934524-10-4 ]

2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.88

Chemical Structure| 252723-17-4

[ 252723-17-4 ]

5-Bromo-4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.83

Chemical Structure| 479633-70-0

[ 479633-70-0 ]

4-Chloro-6-iodo-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.81

Chemical Structure| 1987286-78-1

[ 1987286-78-1 ]

Ethyl 4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate

Similarity: 0.75

Chemical Structure| 1429309-33-0

[ 1429309-33-0 ]

1-((4-Bromophenyl)sulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.73

Sulfamides

Chemical Structure| 348640-02-8

[ 348640-02-8 ]

1-Tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.93

Chemical Structure| 896722-51-3

[ 896722-51-3 ]

6-Methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.89

Chemical Structure| 934524-10-4

[ 934524-10-4 ]

2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.88

Chemical Structure| 348640-07-3

[ 348640-07-3 ]

4-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.86

Chemical Structure| 880769-95-9

[ 880769-95-9 ]

3-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.85

Related Parent Nucleus of
[ 896722-50-2 ]

Other Aromatic Heterocycles

Chemical Structure| 348640-02-8

[ 348640-02-8 ]

1-Tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.93

Chemical Structure| 896722-51-3

[ 896722-51-3 ]

6-Methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.89

Chemical Structure| 934524-10-4

[ 934524-10-4 ]

2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.88

Chemical Structure| 348640-07-3

[ 348640-07-3 ]

4-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.86

Chemical Structure| 880769-95-9

[ 880769-95-9 ]

3-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.85